home / stock / xlrn / xlrn quote
Last: | $178.75 |
---|---|
Change Percent: | -0.52% |
Open: | $179.85 |
Close: | $178.75 |
High: | $179.85 |
Low: | $177.06 |
Volume: | 7,581,781 |
Last Trade Date Time: | 11/19/2021 04:56:52 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$178.75 | $179.85 | $178.75 | $179.85 | $177.06 | 7,581,781 | 11-19-2021 |
$179.68 | $179.71 | $179.68 | $179.78 | $179.66 | 1,025,409 | 11-18-2021 |
$179.68 | $179.9 | $179.68 | $179.94 | $179.52 | 6,009,226 | 11-17-2021 |
$173.98 | $173.31 | $173.98 | $174.5 | $173.17 | 838,292 | 11-16-2021 |
$173.5 | $173.5 | $173.5 | $174.65 | $173.43 | 496,245 | 11-15-2021 |
$173.11 | $173.3 | $173.11 | $173.93 | $172.85 | 834,260 | 11-12-2021 |
$173.3 | $173.33 | $173.3 | $173.8 | $173.13 | 462,038 | 11-11-2021 |
$173 | $174.25 | $173 | $174.5 | $172.9 | 1,392,583 | 11-10-2021 |
$173.99 | $174.52 | $173.99 | $174.89 | $173.87 | 426,690 | 11-09-2021 |
$173.71 | $173.5 | $173.71 | $174.5 | $173.485 | 364,617 | 11-08-2021 |
$173.38 | $174.02 | $173.38 | $174.25 | $172.975 | 520,120 | 11-05-2021 |
$173.73 | $172.83 | $173.73 | $174.35 | $172.83 | 376,351 | 11-04-2021 |
$173.03 | $172.68 | $173.03 | $173.26 | $172.6 | 660,277 | 11-03-2021 |
$172.68 | $173.88 | $172.68 | $173.89 | $172.5 | 925,187 | 11-02-2021 |
$173.87 | $174 | $173.87 | $174.2648 | $173.33 | 759,358 | 11-01-2021 |
$174.18 | $173.91 | $174.18 | $174.74 | $173.26 | 710,238 | 10-29-2021 |
$174.24 | $174.35 | $174.24 | $174.37 | $173.25 | 1,084,092 | 10-28-2021 |
$173.8 | $173.78 | $173.8 | $174.51 | $173.3 | 594,906 | 10-27-2021 |
$173.78 | $173.73 | $173.78 | $174.15 | $173.5 | 245,749 | 10-26-2021 |
$173.78 | $174.41 | $173.78 | $174.57 | $173.51 | 335,689 | 10-25-2021 |
News, Short Squeeze, Breakout and More Instantly...
Acceleron Pharma Inc. Company Name:
XLRN Stock Symbol:
NASDAQ Market:
Acceleron Pharma Inc. Website:
Believes Transaction Comes at the Wrong Time, With the Wrong Price, and Following the Wrong Process Remains Confident in Company’s Standalone Opportunities – Given Strong Momentum and Near-Term Inflection Point Coming from Phase 3 Data Stands Ready to Hel...
In September, Merck (NYSE: MRK) announced plans to acquire Acceleron Pharma (NASDAQ: XLRN) for $11.5 billion. However, the big drugmaker recently revealed that it withdrew a key regulatory filing document related to the transaction. In this Motley Fool Live video ...